Predictive Factors for HBsAg Loss in Chronic HBeAg ‐Negative Hepatitis B Virus Infection: Insights From a 5‐Year French Cohort
Journal of Viral Hepatitis · 2025
DOI: 10.1111/jvh.14041 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Viral Hepatitis, 2025. Verfasst von Xavier Causse und 9 weiteren Autor:innen. Beteiligte Einrichtung: Service d'Hépato-Gastroentérologie et d'Oncologie Digestive, Centre Hospitalier Universitaire d'Orléans, Orléans, France. Hauptthemen laut MEDLINE: Hepatitis B, Chronic, Hepatitis B Surface Antigens, Hepatitis B e Antigens, Hepatitis B virus. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Association Nationale des Hépato-Gastroentérologues des hôpitaux généraux (ANGH), People’s Liberation Army Navy General Hospital.
Abstract (Originalsprache)
Prognostic factors for the long‐term evolution of chronic hepatitis B e antigen (HBeAg)‐negative hepatitis B virus (HBV) infection may vary depending on local epidemiology. We aimed to identify these factors in France, where the epidemiology is influenced by diverse immigration. Hepatitis B surface antigen (HBsAg)‐positive, HBeAg‐negative adults with normal transaminase levels and viral loads < 20,000 IU/mL for 1 year, without viral co‐infection or advanced liver disease, were enrolled for a 5‐year follow‐up. A total of 564 patients were recruited from 23 centres (54.4% women, mean age 42.3 ± 12 years, 47.7% from sub‐Saharan Africa). HBV DNA was detectable but < 2000 IU/mL for most (71.3%). Genotypes E (27.8%) and A (20.0%) were predominant. The mean HBsAg titre was 3.8 ± 3.4 log IU/mL, > 1000 IU/mL in 60% of cases, and higher in genotype E ( p < 0.0001). During follow‐up, 18 patients received antiviral treatment, 9 for viral reactivation (0.3% per year) and 9 preemptively. HBsAg loss occurred in 39 patients (1.4% per year). These patients were older ( p < 0.0001), more frequently treated for dyslipidemia, hypertension or diabetes ( p < 0.05), and had lower baseline HBV DNA ( p = 0.0112) and HBsAg ( p < 0.0001), but similar levels of HBcrAg compared to those who did not clear HBsAg. Baseline HBsAg was the only independent predictor of HBsAg loss ( p = 0.009). In this cohort, HBsAg < 153 IU/mL predicted clearance with 87% sensitivity and specificity. In conclusion, baseline HBsAg accurately predicted seroclearance at 5 years in patients with chronic HBeAg‐negative infection, regardless of genotype, sex, or geographical origin, indicating that this marker is widely applicable for reducing the frequency of patient monitoring.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Service d'Hépato-Gastroentérologie et d'Oncologie Digestive, Centre Hospitalier Universitaire d'Orléans, Orléans, France.
- Département d'Information Médicale, Centre Hospitalier Universitaire d'Orléans, Orléans, France.
- Service d'Hépato-Gastroentérologie, Centre Hospitalier de Saint Denis, Saint Denis, France.
- Groupe Hospitalier Intercommunal Le Raincy-Montfermeil, Service d'Hépato-Gastroentérologie, Le Raincy Montfermeil, France.
- Groupe Hospitalier Public du Sud de l'Oise, Service d'Hépato-Gastroentérologie, Creil, France.
- Private Medical Practice, Maubec, France.
ORCID-Profile: Anne-Marie Roque-Afonso
Förderung
- Association Nationale des Hépato-Gastroentérologues des hôpitaux généraux (ANGH)
- People’s Liberation Army Navy General Hospital
Zitieren
APA
Causse, X., Potier, P., Valéry, A., Labadie, H., Macaigne, G., Cadranel, J. F., Fontanges, T., Mouna, L., Roque-Afonso, A. M., & PIBAC Study Group of Association Nationale des Hépato‐Gastroentérologues des Hôpitaux Généraux (ANGH) (2025). Predictive Factors for HBsAg Loss in Chronic HBeAg ‐Negative Hepatitis B Virus Infection: Insights From a 5‐Year French Cohort. Journal of Viral Hepatitis. https://doi.org/10.1111/jvh.14041
Vancouver
Causse X, Potier P, Valéry A, Labadie H, Macaigne G, Cadranel JF, et al. Predictive Factors for HBsAg Loss in Chronic HBeAg ‐Negative Hepatitis B Virus Infection: Insights From a 5‐Year French Cohort. Journal of Viral Hepatitis. 2025. doi:10.1111/jvh.14041
BibTeX
@article{Causse2025,
author = {Causse, Xavier and Potier, Pascal and Valéry, Antoine and Labadie, Hélène and Macaigne, Gilles and Cadranel, Jean-François and Fontanges, Thierry and Mouna, Lina and Roque-Afonso, Anne-Marie and PIBAC Study Group of Association Nationale des Hépato‐Gastroentérologues des Hôpitaux Généraux (ANGH), PIBAC Study Group of Association Nationale des Hépato‐Gastroentérologues des Hôpitaux Généraux (ANGH)},
title = {Predictive Factors for HBsAg Loss in Chronic HBeAg ‐Negative Hepatitis B Virus Infection: Insights From a 5‐Year French Cohort},
journal = {Journal of Viral Hepatitis},
year = {2025},
doi = {10.1111/jvh.14041}
}
EUVIMED